Tricuspid Regurgitation Clinical Trials Database - Free Access to 49 Studies
Access comprehensive clinical trial information for Tricuspid Regurgitation through Pure Global AI's free database. This collection includes 49 clinical trials across multiple phases including N/A, Not Applicable, Phase 1. Currently, 22 trials are actively recruiting participants.
Research for Tricuspid Regurgitation is being conducted in United States of America, China, Italy and 7+ other countries. Leading sponsors include Michele De Bonis and Shanghai Huihe Medical Technology Co., Ltd. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
A First in Human Study for the Versa Device for Tricuspid Regurgitation
Assessing the Right Heart Remodeling After Transcatheter Tricuspid Edge-to-edge Repair
Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment
Outcome of Patients With Severe Functional TR According to Medical, Transcatheter or Surgical Treatment
A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Efficacy and Safety of the Transcatheter Tricuspid Valvuloplasty System in Patients With Severe or Above Tricuspid Regurgitation
Tricuspid Regurgitation in the ElderlY
Long-term Outcomes of Isolated Tricuspid Valve Surgery According to Preoperative Clinical and Functional Staging
Surgical Treatment of Tricuspid Valve Regurgitation in Patients With Cardiac Implantable Electronic Devices: Long Term Results
Very Long-term (15 Years) Results of Tricuspid Valve Repair.
SGLT2 Inhibitor for Severe Tricuspid Regurgitation
Feasibility Study of the DragonFly-T System for Severe Tricuspid Regurgitation
Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation
Dawneo Neoblazar® Transcatheter Tricuspid Valve Edge-to Edge Repair System Pivotal Clinical Trial in Patients With Severe Tricuspid Regurgitation
Safety and Performance of the Cardiovalve TR Replacement System
Feasibility Study of Treating Tricuspid Regurgitation With K-ClipTM Transcatheter Annuloplasty System
A Prospective, Multi-center Study to Evaluate the Safety and Performance of LuX-Valve Plus System for Tricuspid Replacement
PASCAL for Tricuspid Regurgitation - a European Registry
A Feasibility Study of the CroíValve DUO System for Tricuspid Regurgitation
Confirmatory Clinical Study of Treating Tricuspid Regurgitation With K-Clip TM Transcatheter Annuloplasty System
Measurement of Tricuspid Regurgitation Volume for Assessment of Tricuspid Regurgitation Using 3D Transesophageal Echocardiography
Pure Global AI provides free access to 49 clinical trials studying Tricuspid Regurgitation, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Michele De Bonis, Shanghai Huihe Medical Technology Co., Ltd, Hangzhou Valgen Medtech Co., Ltd, among others.